drugset / Trial / NCT01681277

Safety, Tolerability and Pharmacokinetics of Multiple Rising Doses of BI 113608 in Healthy Male Volunteers

NCT01681277

Phase 1 Completed 48 enrolled Boehringer Ingelheim
RandomizedSingle-groupDouble-blindTreatment

Summary

The objective of the current trial is to evaluate safety, tolerability and pharmacokinetics of multiple rising doses of BI 113608 in healthy male volunteers

Timeline

Start
2012-09
Primary completion
2013-05
Completion
2013-05

Drugs

EvaluationDrugModalityDoseRoute
Subject BI 113608 Unknown Oral

Indications

No indication recorded.